Cargando…
Expanding the Malaria Antibody Toolkit: Development and Characterisation of Plasmodium falciparum RH5, CyRPA, and CSP Recombinant Human Monoclonal Antibodies
Malaria, an infection caused by apicomplexan parasites of the genus Plasmodium, continues to exact a significant toll on public health with over 200 million cases world-wide, and annual deaths in excess of 600,000. Considerable progress has been made to reduce malaria burden in endemic countries in...
Autores principales: | Nacer, Adéla, Kivi, Gaily, Pert, Raini, Juronen, Erkki, Holenya, Pavlo, Aliprandini, Eduardo, Amino, Rogerio, Silvie, Olivier, Quinkert, Doris, Le Duff, Yann, Hurley, Matthew, Reimer, Ulf, Tover, Andres, Draper, Simon J., Gilbert, Sarah, Ho, Mei Mei, Bowyer, Paul W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9243361/ https://www.ncbi.nlm.nih.gov/pubmed/35782147 http://dx.doi.org/10.3389/fcimb.2022.901253 |
Ejemplares similares
-
Generation of Plasmodium falciparum parasite-inhibitory antibodies by immunization with recombinantly-expressed CyRPA
por: Favuzza, Paola, et al.
Publicado: (2016) -
Structural basis for inhibition of erythrocyte invasion by antibodies to Plasmodium falciparum protein CyRPA
por: Chen, Lin, et al.
Publicado: (2017) -
Strain-Dependent Inhibition of Erythrocyte Invasion by Monoclonal Antibodies Against Plasmodium falciparum CyRPA
por: Knudsen, Anne S., et al.
Publicado: (2021) -
Structure of the malaria vaccine candidate antigen CyRPA and its complex with a parasite invasion inhibitory antibody
por: Favuzza, Paola, et al.
Publicado: (2017) -
The RH5-CyRPA-Ripr Complex as a Malaria Vaccine Target
por: Ragotte, Robert J., et al.
Publicado: (2020)